Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity
Angewandte Chemie International Edition · 06.03.2023 · 62 (11)
DOI: 10.1002/anie.202217532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 02.02.2023. Verfasst von Václav Němec und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic. Hauptthemen laut MEDLINE: Casein Kinase I, Signal Transduction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Ministerstvo Školství, Mládeže a Tělovýchovy, Bader Philanthropies.
Abstract (Originalsprache)
Casein kinases 1 (CK1) are key signaling molecules that have emerged recently as attractive therapeutic targets in particular for the treatment of hematological malignancies. Herein, we report the identification of a new class of potent and highly selective inhibitors of CK1α, δ and ϵ. Based on their optimal in vitro and in vivo profiles and their exclusive selectivity, MU1250, MU1500 and MU1742 were selected as quality chemical probes for those CK1 isoforms. At proper concentrations, MU1250 and MU1500 allow for specific targeting of CK1δ or dual inhibition of CK1δ/ϵ in cells. The compound MU1742 also efficiently inhibits CK1α and, to our knowledge, represents the first potent and highly selective inhibitor of this enzyme. In addition, we demonstrate that the central 1 H ‐pyrrolo[2,3‐ b ]pyridine‐imidazole pharmacophore can be used as the basis of highly selective inhibitors of other therapeutically relevant protein kinases, e.g. p38α, as exemplified by the compound MU1299.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
- International Clinical Research Centre, St. Anne's University Hospital, Pekařská 53, Brno, 656 91, Czech Republic.
- Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
- Institute for Pharmaceutical Chemistry, Structural Genomics Consortium, Johann Wolfgang Goethe-University, Max-von-Laue-Strasse 15, 60438, Frankfurt am Main, Germany.
- Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, 85354, Freising, Germany.
- Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, 85354, Freising, Germany.
ORCID-Profile: Prashant Khirsariya, Vítězslav Bryja, Kamil Paruch
Förderung
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Bader Philanthropies
Zitieren
APA
Němec, V., Khirsariya, P., Janovská, P., Moyano, P. M., Maier, L., Procházková, P., Kebková, P., Gybel', T., Berger, B. T., Chaikuad, A., Reinecke, M., Kuster, B., Knapp, S., Bryja, V., & Paruch, K. (2023). Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity. Angewandte Chemie International Edition, 62(11). https://doi.org/10.1002/anie.202217532
Vancouver
Němec V, Khirsariya P, Janovská P, Moyano PM, Maier L, Procházková P, et al. Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity. Angewandte Chemie International Edition. 2023;62(11). doi:10.1002/anie.202217532
BibTeX
@article{Nmec2023,
author = {Němec, Václav and Khirsariya, Prashant and Janovská, Pavlína and Moyano, Paula Martín and Maier, Lukáš and Procházková, Petra and Kebková, Pavlína and Gybel', Tomáš and Berger, Benedict-Tilman and Chaikuad, Apirat and Reinecke, Maria and Kuster, Bernhard and Knapp, Stefan and Bryja, Vítězslav and Paruch, Kamil},
title = {Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {11},
doi = {10.1002/anie.202217532}
}
EUVIMED